Association between abnormal lipid profile and inflammation and progression of myelodysplastic syndrome to acute leukemia

Keypoints Elevated triglyceride and high-sensitive CRP are associated with a higher risk of acute leukemia in MDS.

Bibliographic Details
Main Authors:	Wei Qiao, Elliana Young, Chun Feng, Suyu Liu, Jeff Jin, Laila Noor, Cristhiam M. Rojas Hernandez, Gautam Borthakur, Olga Gorlova, Vahid Afshar-Kharghan
Format:	Article
Language:	English
Published:	BMC 2022-09-01
Series:	Experimental Hematology & Oncology
Subjects:	Myelodysplastic syndrome Acute Myeloid Leukemia Clonal hematopoiesis Inflammation Triglyceride
Online Access:	https://doi.org/10.1186/s40164-022-00309-7

Similar Items

Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia
by: Alexander J. Ambinder, et al.
Published: (2022-10-01)

Stem Cells in the Myelodysplastic Syndromes
by: Di Zhan, et al.
Published: (2021-07-01)

Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series
by: Grégoire Martin de Frémont, et al.
Published: (2021-10-01)

Clonal hematopoiesis and acute myeloid leukemia
by: A. I. Kashlakova, et al.
Published: (2023-09-01)

Editorial: Immunobiology and immunotherapeutics in myelodysplastic syndrome and acute myeloid leukemia
by: Shyam A. Patel, et al.
Published: (2024-10-01)

Preleukemic Hematopoietic Stem Cells in Human Acute Myeloid Leukemia
by: M. Ryan Corces, et al.
Published: (2017-11-01)

Single-Cell Technologies to Decipher the Immune Microenvironment in Myeloid Neoplasms: Perspectives and Opportunities
by: Chiara Caprioli, et al.
Published: (2022-02-01)

Corrigendum: Single-cell technologies to decipher the immune microenvironment in myeloid neoplasms: Perspectives and opportunities
by: Chiara Caprioli, et al.
Published: (2022-08-01)

Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions
by: Shyam A. Patel, et al.
Published: (2023-11-01)

Association of loss of heterozygosity with cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome
by: R.F. Pinheiro, et al.
Published: (2008-07-01)

Predictors of vascular disease in myelodysplastic syndromes
by: Mark G. Faber, et al.
Published: (2020-11-01)

Characterisation of Myeloid, Lymphiod and Erythroid Cell Lineages in Myelodysplastics Syndrome Using Flow Cytometry
by: Broojerdi, Mohadese Hashem
Published: (2011)

Transformation of secondary myelodysplastic syndrome to atypical chronic myeloid leukemia in a female patient with acute myeloid leukemia
by: S V Gritsaev, et al.
Published: (2016-07-01)

Diagnosis of Myelodysplastic Syndromes: From Immunological Observations to Clinical Applications
by: Yannick Simoni, et al.
Published: (2022-07-01)

Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome: Bursa Uludag University Experience
by: İbrahim Ethem Pınar, et al.
Published: (2021-03-01)

Transformation of a myelodysplastic syndrome to acute myeloid leukemia and concurrent necrotizing sweet syndrome
by: Olga Vera-Lastra, et al.
Published: (2021-03-01)

Gingival enlargement in myelodysplastic syndrome
by: Navia George, et al.
Published: (2015-01-01)

What Clonal Hematopoiesis Can Teach Us About MDS
by: Irenaeus C. C. Chan, et al.
Published: (2022-02-01)

Difficulties in the differential diagnosis of myelodysplastic syndrome and acute leukemia
by: Alina V. Maltseva, et al.
Published: (2023-05-01)

Polyclonal evolution of Fanconi anemia to MDS and AML revealed at single cell resolution
by: Lixian Chang, et al.
Published: (2022-09-01)

Spontaneous remission of acute myeloid leukemia with NF1 alteration
by: Terrence Bradley, et al.
Published: (2020-01-01)

Common in atherogenesis and carcinogenesis: clonal hematopoiesis
by: A. A. Sleptsov, et al.
Published: (2023-11-01)

Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
by: Huai-Hsuan Huang, et al.
Published: (2019-06-01)

Editorial: Uncovering the relationship between myelodysplastic syndromes and acute myeloid leukemia
by: Mohamed A. Yassin, et al.
Published: (2023-01-01)

Extramedullary hematopoiesis in the axillary lymph node in a patient with an accelerated phase of chronic myeloid leukemia
by: Gülşah Kaygusuz, et al.
Published: (2009-03-01)

Therapy related acute myeloid leukemia with t(10:16): a rare entity
by: Guldeep K. Uppal, et al.
Published: (2011-12-01)

Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase I studies
by: Uwe Platzbecker, et al.
Published: (2022-05-01)

Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Georgios Petros Barakos, et al.
Published: (2022-06-01)

Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia
by: Vincent G. Sorrentino, et al.
Published: (2021-07-01)

Extramedullary Hematopoiesis in Myelodysplastic Syndromes: A Systematic Literature Review
by: Chen Wang, et al.
Published: (2022-09-01)

Laboratory diagnostics stages of myelodysplastic syndrome transformation into acute erythroid leukemia (clinical case report)
by: I. E. Volgina
Published: (2022-01-01)

STAT signaling in the pathogenesis and therapy of acute myeloid leukemia and myelodysplastic syndromes
by: Zoe King, et al.
Published: (2025-03-01)

Focal blast crisis in concomitant myelodysplastic syndrome and chronic myelogenous leukemia
by: Leo Reap, DO, et al.
Published: (2020-01-01)

The efficacy and safety of venetoclax and azacytidine combination treatment in patients with acute myeloid leukemia and myelodysplastic syndrome: systematic review and meta-analysis
by: Yufeng Du, et al.
Published: (2023-12-01)

From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression
by: Carmelo Gurnari, et al.
Published: (2021-02-01)

The dark side of stemness – the role of hematopoietic stem cells in development of blood malignancies
by: Jadwiga Filipek-Gorzała, et al.
Published: (2024-02-01)

Salvage Therapy after Allogeneic Hematopoietic Cell Transplantation: Targeted and Low-Intensity Treatment Options in Myelodysplastic Syndrome and Acute Myeloid Leukemia
by: Katie Culos, et al.
Published: (2019-05-01)

A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome
by: Wei Guoqing, et al.
Published: (2011-11-01)

Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism
by: Guangjie Zhao, et al.
Published: (2021-09-01)

Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
by: Yasmin Abaza, et al.
Published: (2022-07-01)